Hisamitsu Pharmaceutical Co., Inc. engages in the research, development, manufacture, and sale of pharmaceuticals and related products. The company is headquartered in Chiyoda-Ku, Tokyo-To and currently employs 2,799 full-time employees. The firm is engaged in the manufacture, sale and supply of pharmaceuticals and related products, and the operation of over-the-counter drug (OTC) business. The company is also engaged in the manufacture and sale of drugs in the United States, Brazil, Vietnam, and Indonesia, the development work in Europe, the drug marketing and sales in China and Hong Kong. The company is also engaged in the urban cable television broadcasting business, Internet connection service business, non-life insurance agency business, advertising agency business and the purchase, manufacture and sale of packing materials.
Hisamitsu Pharmaceutical Co Inc'in temel mali tabloları nelerdir?
Son mali tabloya (Form-10K) göre, Hisamitsu Pharmaceutical Co Inc'in toplam varlıkları $343,068 olup, net 이익 $21,758'dir.
HTSUY'ün temel finansal oranları nelerdir?
Hisamitsu Pharmaceutical Co Inc'in cari oranı 5.17, net kâr marjı 13.94, hisse başına satış $2,116.23'dir.
Hisamitsu Pharmaceutical Co Inc'in geliri segment veya coğrafya bazında nasıl dağılıyor?
Hisamitsu Pharmaceutical Co Inc 주요 수익원은 Pharmaceuticals이며, 최신 수익 발표에서 수익은 152,654,000,000입니다. 지역별로는 Japan이 Hisamitsu Pharmaceutical Co Inc의 주요 시장이며, 수익은 82,364,000,000입니다.
Hisamitsu Pharmaceutical Co Inc kârlı mı?
예, son mali tablolara göre Hisamitsu Pharmaceutical Co Inc'in net 이익 $21,758'dir.
Hisamitsu Pharmaceutical Co Inc'in herhangi bir yükümlülüğü var mı?
예, Hisamitsu Pharmaceutical Co Inc'in yükümlülüğü 66,242'dir.
Hisamitsu Pharmaceutical Co Inc'in tedavüldeki hisse sayısı kaçtır?
Hisamitsu Pharmaceutical Co Inc'in toplam tedavüldeki hisse sayısı 72.96'dir.